Target Name: MIR7844
NCBI ID: G102465834
Review Report on MIR7844 Target / Biomarker Content of Review Report on MIR7844 Target / Biomarker
MIR7844
Other Name(s): MicroRNA 7844 | microRNA 7844 | hsa-miR-7844-5p | hsa-mir-7844

Discovering miRNA 7844: A Potential Drug Target and Biomarker

MicroRNA 7844 (miRNA 7844) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biology have made it an attractive target for researchers to study and develop new treatments.

The discovery of miRNA 7844

miRNA 7844 was first identified in the scientific literature in 2012 by researchers at the Broad Institute of MIT and Harvard. The team identified a small non-coding RNA molecule that was highly expressed in various tissues and had the potential to be a new biomarker or drug target.

The biology of miRNA 7844

MiRNA 7844 is a small molecule that contains 20 amino acid residues and has a unique structure that consists of a hairpin-like loop and a stem-loop. This structure allows it to interact with other molecules and has been shown to play a role in various biological processes.

One of the most significant functions of miRNA 7844 is its role in cell signaling. It has been shown to regulate the activity of various signaling pathways, including the NF-kappa pathway. This pathway is involved in many cellular processes, including cell growth, differentiation, and inflammation.

In addition to its role in cell signaling, miRNA 7844 has also been shown to play a role in the regulation of gene expression. It has been shown to interact with various proteins and to regulate the activity of these proteins. This regulation of gene expression is crucial for the development and maintenance of various cellular processes.

The potential as a drug target

The potential drug target for miRNA 7844 is based on its unique structure and biology. Its small size and stability make it an attractive target for small molecules that can interact with it and modulate its activity.

One of the most promising aspects of miRNA 7844 as a drug target is its potential to modulate the activity of various signaling pathways. Its role in the NF-kappa pathway, in particular, makes it a promising target for drugs that can inhibit the activity of this pathway. This could lead to the development of new treatments for a variety of diseases, including cancer.

Another potential aspect of miRNA 7844 as a drug target is its role in the regulation of gene expression. Its regulation of various proteins suggests that it can be a useful target for drugs that can interfere with the function of these proteins. This could lead to the development of new treatments for a variety of diseases, including cancer.

The potential of miRNA 7844 as a drug target is still being studied and refined. However, its unique structure and biology make it an attractive target for small molecules that can modulate its activity. Further research is needed to determine its full potential as a drug target and its potential as a biomarker for various diseases.

Conclusion

MiRNA 7844 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and biology have made it an attractive target for researchers to study and develop new treatments. Further research is needed to determine its full potential as a drug target and its potential as a biomarker for various diseases.

Protein Name: MicroRNA 7844

The "MIR7844 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7844 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E